161 related articles for article (PubMed ID: 8413674)
41. Antibody binding defines a structure for an epitope that participates in the PrPC-->PrPSc conformational change.
Kanyo ZF; Pan KM; Williamson RA; Burton DR; Prusiner SB; Fletterick RJ; Cohen FE
J Mol Biol; 1999 Nov; 293(4):855-63. PubMed ID: 10543972
[TBL] [Abstract][Full Text] [Related]
42. Antibody multispecificity mediated by conformational diversity.
James LC; Roversi P; Tawfik DS
Science; 2003 Feb; 299(5611):1362-7. PubMed ID: 12610298
[TBL] [Abstract][Full Text] [Related]
43. Structural insights into parallel strategies for germline antibody recognition of lipopolysaccharide from Chlamydia.
Evans DW; Müller-Loennies S; Brooks CL; Brade L; Kosma P; Brade H; Evans SV
Glycobiology; 2011 Aug; 21(8):1049-59. PubMed ID: 21543444
[TBL] [Abstract][Full Text] [Related]
44. Analysis of an anti-progesterone antibody: variable crystal morphology of the Fab' and steroid-Fab' complexes.
Stura EA; Arevalo JH; Feinstein A; Heap RB; Taussig MJ; Wilson IA
Immunology; 1987 Dec; 62(4):511-21. PubMed ID: 3123368
[TBL] [Abstract][Full Text] [Related]
45. Monoclonal antibodies against progesterone: effect of steroid-carrier coupling position on antibody specificity.
Gani M; Coley J; Piron J; Humphreys AS; Arevalo J; Wilson IA; Taussig MJ
J Steroid Biochem Mol Biol; 1994 Feb; 48(2-3):277-82. PubMed ID: 8142304
[TBL] [Abstract][Full Text] [Related]
46. Influence of the conjugation site on the specificity of monoclonal antibodies to progesterone and on the performance of direct enzyme immunoassay.
Yoon DY; Choi MJ; Choe IS; Chung TW; Byun SM
Biochem Mol Biol Int; 1993 Nov; 31(3):553-63. PubMed ID: 8118431
[TBL] [Abstract][Full Text] [Related]
47. Crystal structure to 2.45 A resolution of a monoclonal Fab specific for the Brucella A cell wall polysaccharide antigen.
Rose DR; Przybylska M; To RJ; Kayden CS; Oomen RP; Vorberg E; Young NM; Bundle DR
Protein Sci; 1993 Jul; 2(7):1106-13. PubMed ID: 8358294
[TBL] [Abstract][Full Text] [Related]
48. [Features of interaction of monoclonal antibody B2 with polycyclicaromatic hydrocarbons and peptide-mimotope of benzo[a]pyrene].
Glushko AN; Apal'ko SV; Bakulina AIu; Matveeva VA; Khrapov EA; Kostianko MV; Sil'nikov VN; Filipenko ML
Mol Biol (Mosk); 2010; 44(4):699-707. PubMed ID: 20873230
[TBL] [Abstract][Full Text] [Related]
49. Energetic analysis of binding of progesterone and 5 beta-androstane-3,17-dione to anti-progesterone antibody DB3 using molecular dynamics and free energy calculations.
Peräkylä M; Nordman N
Protein Eng; 2001 Oct; 14(10):753-8. PubMed ID: 11739893
[TBL] [Abstract][Full Text] [Related]
50. Sequence, specificity and crystallization of an oestrone-3-glucuronide antibody (3910).
He M; Gani M; Livnah O; Stura EA; Beale D; Coley J; Wilson IA; Taussig MJ
Immunology; 1997 Apr; 90(4):632-9. PubMed ID: 9176119
[TBL] [Abstract][Full Text] [Related]
51. Structural basis of antibody-antigen interactions.
Sundberg EJ
Methods Mol Biol; 2009; 524():23-36. PubMed ID: 19377934
[TBL] [Abstract][Full Text] [Related]
52. Preparation and biomedical applications of bispecific antibodies.
Paulus H
Behring Inst Mitt; 1985 Dec; (78):118-32. PubMed ID: 3833240
[TBL] [Abstract][Full Text] [Related]
53. 26-10 Fab-digoxin complex: affinity and specificity due to surface complementarity.
Jeffrey PD; Strong RK; Sieker LC; Chang CY; Campbell RL; Petsko GA; Haber E; Margolies MN; Sheriff S
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10310-4. PubMed ID: 8234291
[TBL] [Abstract][Full Text] [Related]
54. Binding of the neuroleptic drug haloperidol to a monoclonal antibody: refinement of the binding site molecular model using canonical structures.
Anchin JM; Subramaniam S; Linthicum DS
J Mol Recognit; 1991 Feb; 4(1):7-15. PubMed ID: 1931126
[TBL] [Abstract][Full Text] [Related]
55. Structure, function and properties of antibody binding sites.
Mian IS; Bradwell AR; Olson AJ
J Mol Biol; 1991 Jan; 217(1):133-51. PubMed ID: 1988675
[TBL] [Abstract][Full Text] [Related]
56. Structure of the Fab fragment from F124, a monoclonal antibody specific for hepatitis B surface antigen.
Saul FA; Vulliez-Le Normand B; Passafiume M; Riottot MM; Bentley GA
Acta Crystallogr D Biol Crystallogr; 2000 Aug; 56(Pt 8):945-51. PubMed ID: 10944330
[TBL] [Abstract][Full Text] [Related]
57. Three-dimensional quantitative structure-activity relationship analysis of ligand binding to human sequence antidigoxin monoclonal antibodies using comparative molecular field analysis.
Farr CD; Tabet MR; Ball WJ; Fishwild DM; Wang X; Nair AC; Welsh WJ
J Med Chem; 2002 Jul; 45(15):3257-70. PubMed ID: 12109909
[TBL] [Abstract][Full Text] [Related]
58. Structural insights into steroid hormone binding: the crystal structure of a recombinant anti-testosterone Fab fragment in free and testosterone-bound forms.
Valjakka J; Takkinenz K; Teerinen T; Söderlund H; Rouvinen J
J Biol Chem; 2002 Feb; 277(6):4183-90. PubMed ID: 11707437
[TBL] [Abstract][Full Text] [Related]
59. Closely related antibody receptors exploit fundamentally different strategies for steroid recognition.
Verdino P; Aldag C; Hilvert D; Wilson IA
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11725-30. PubMed ID: 18689687
[TBL] [Abstract][Full Text] [Related]
60. Antigen clasping by two antigen-binding sites of an exceptionally specific antibody for histone methylation.
Hattori T; Lai D; Dementieva IS; Montaño SP; Kurosawa K; Zheng Y; Akin LR; Świst-Rosowska KM; Grzybowski AT; Koide A; Krajewski K; Strahl BD; Kelleher NL; Ruthenburg AJ; Koide S
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2092-7. PubMed ID: 26862167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
